PACS vs. MEDP: Which Stock Is the Better Value Option?

Core Viewpoint - PACS Group, Inc. is currently viewed as a more attractive investment option compared to Medpace based on valuation metrics and earnings estimate revisions [3][7]. Valuation Metrics - PACS has a forward P/E ratio of 17.43, significantly lower than Medpace's forward P/E of 27.34 [5]. - The PEG ratio for PACS is 1.16, while Medpace has a PEG ratio of 2.23, indicating PACS is more favorably valued in relation to its expected earnings growth [5]. - PACS's P/B ratio stands at 5.98, compared to Medpace's P/B of 28.58, further highlighting PACS's relative undervaluation [6]. Analyst Outlook - PACS holds a Zacks Rank of 1 (Strong Buy), indicating a positive earnings estimate revision trend, while Medpace has a Zacks Rank of 3 (Hold) [3]. - The stronger estimate revision activity for PACS suggests a more favorable analyst outlook compared to Medpace [7]. Value Grades - PACS has a Value grade of B, whereas Medpace has a Value grade of C, reflecting PACS's superior valuation metrics [6].